137 related articles for article (PubMed ID: 32220421)
1. Role of oral microbiota in atherosclerosis.
Liu XR; Xu Q; Xiao J; Deng YM; Tang ZH; Tang YL; Liu LS
Clin Chim Acta; 2020 Jul; 506():191-195. PubMed ID: 32220421
[TBL] [Abstract][Full Text] [Related]
2. Role of gut microbiota in atherosclerosis.
Jonsson AL; Bäckhed F
Nat Rev Cardiol; 2017 Feb; 14(2):79-87. PubMed ID: 27905479
[TBL] [Abstract][Full Text] [Related]
3. Human oral, gut, and plaque microbiota in patients with atherosclerosis.
Koren O; Spor A; Felin J; Fåk F; Stombaugh J; Tremaroli V; Behre CJ; Knight R; Fagerberg B; Ley RE; Bäckhed F
Proc Natl Acad Sci U S A; 2011 Mar; 108 Suppl 1(Suppl 1):4592-8. PubMed ID: 20937873
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles for dietary lipids and Porphyromonas gingivalis infection on atherosclerosis progression and the gut microbiota.
Kramer CD; Simas AM; He X; Ingalls RR; Weinberg EO; Genco CA
Anaerobe; 2017 Jun; 45():19-30. PubMed ID: 28442421
[TBL] [Abstract][Full Text] [Related]
5. Polymicrobial Oral Infection with Four Periodontal Bacteria Orchestrates a Distinct Inflammatory Response and Atherosclerosis in ApoE null Mice.
Chukkapalli SS; Velsko IM; Rivera-Kweh MF; Zheng D; Lucas AR; Kesavalu L
PLoS One; 2015; 10(11):e0143291. PubMed ID: 26619277
[TBL] [Abstract][Full Text] [Related]
6. Oral microbiota in patients with atherosclerosis.
Fåk F; Tremaroli V; Bergström G; Bäckhed F
Atherosclerosis; 2015 Dec; 243(2):573-8. PubMed ID: 26536303
[TBL] [Abstract][Full Text] [Related]
7. A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis.
Brandsma E; Kloosterhuis NJ; Koster M; Dekker DC; Gijbels MJJ; van der Velden S; Ríos-Morales M; van Faassen MJR; Loreti MG; de Bruin A; Fu J; Kuipers F; Bakker BM; Westerterp M; de Winther MPJ; Hofker MH; van de Sluis B; Koonen DPY
Circ Res; 2019 Jan; 124(1):94-100. PubMed ID: 30582442
[TBL] [Abstract][Full Text] [Related]
8. Quercetin reduces atherosclerotic lesions by altering the gut microbiota and reducing atherogenic lipid metabolites.
Nie J; Zhang L; Zhao G; Du X
J Appl Microbiol; 2019 Dec; 127(6):1824-1834. PubMed ID: 31509634
[TBL] [Abstract][Full Text] [Related]
9. Act Locally, Act Globally-Microbiota, Barriers, and Cytokines in Atherosclerosis.
Kurilenko N; Fatkhullina AR; Mazitova A; Koltsova EK
Cells; 2021 Feb; 10(2):. PubMed ID: 33562334
[TBL] [Abstract][Full Text] [Related]
10. Acrolein increases macrophage atherogenicity in association with gut microbiota remodeling in atherosclerotic mice: protective role for the polyphenol-rich pomegranate juice.
Rom O; Korach-Rechtman H; Hayek T; Danin-Poleg Y; Bar H; Kashi Y; Aviram M
Arch Toxicol; 2017 Apr; 91(4):1709-1725. PubMed ID: 27696135
[TBL] [Abstract][Full Text] [Related]
11. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
12. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis.
Hajishengallis G; Sharma A; Russell MW; Genco RJ
Ann Periodontol; 2002 Dec; 7(1):72-8. PubMed ID: 16013219
[TBL] [Abstract][Full Text] [Related]
13. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
[TBL] [Abstract][Full Text] [Related]
14. The Helicobacter cinaedi antigen CAIP participates in atherosclerotic inflammation by promoting the differentiation of macrophages in foam cells.
D'Elios MM; Vallese F; Capitani N; Benagiano M; Bernardini ML; Rossi M; Rossi GP; Ferrari M; Baldari CT; Zanotti G; de Bernard M; Codolo G
Sci Rep; 2017 Jan; 7():40515. PubMed ID: 28074932
[TBL] [Abstract][Full Text] [Related]
15. Roles of Oral Infections in the Pathomechanism of Atherosclerosis.
Aarabi G; Heydecke G; Seedorf U
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986441
[TBL] [Abstract][Full Text] [Related]
16. Oral challenge with Streptococcus sanguinis induces aortic inflammation and accelerates atherosclerosis in spontaneously hyperlipidemic mice.
Hashizume-Takizawa T; Yamaguchi Y; Kobayashi R; Shinozaki-Kuwahara N; Saito M; Kurita-Ochiai T
Biochem Biophys Res Commun; 2019 Dec; 520(3):507-513. PubMed ID: 31610917
[TBL] [Abstract][Full Text] [Related]
17. Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis.
Slocum C; Kramer C; Genco CA
J Intern Med; 2016 Jul; 280(1):114-28. PubMed ID: 26791914
[TBL] [Abstract][Full Text] [Related]
18. Mediators between oral dysbiosis and cardiovascular diseases.
Pietiäinen M; Liljestrand JM; Kopra E; Pussinen PJ
Eur J Oral Sci; 2018 Oct; 126 Suppl 1():26-36. PubMed ID: 30178551
[TBL] [Abstract][Full Text] [Related]
19. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
[TBL] [Abstract][Full Text] [Related]
20. Lipin-1 contributes to modified low-density lipoprotein-elicited macrophage pro-inflammatory responses.
Navratil AR; Vozenilek AE; Cardelli JA; Green JM; Thomas MJ; Sorci-Thomas MG; Orr AW; Woolard MD
Atherosclerosis; 2015 Oct; 242(2):424-32. PubMed ID: 26288136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
